D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

Q3 2025 Earnings Conference Call May 16, 2025 10:30 AM ETCompany ParticipantsAnn Thornton - Chief Financial Officer ...

Acer today announced powerful new 14-inch Predator gaming laptops designed for gamers and creative professionals. With a set ...

Schemes are selected on the basis of a robust selection methodology. Parameteric evaluation comprising Rolling Returns, Downside Risk and Consistency (measured by Hurst Exponent) are employed to ...